Nine hundred fifty-one of a total of 3882 (24.5%) variants, including 679 of the 1112 (61%) variants in the JAK2 V617F hotspot, were found in participants with prevalent hematologic malignancies (fig. Here, JAK2 is linked to hematologic disorder.